Drug intelligence / Profile preview

zinc aspartate

Development stage
Phase 2
Lead developer
Vector Vitale
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Zinc aspartate is a chelated zinc supplement, a salt formed from zinc and the amino acid aspartic acid. It is typically a white crystalline powder. This form of zinc is favored for its enhanced bioavailability and absorption due to the chelation with aspartate. It is widely used to treat and prevent zinc deficiencies, which can impact numerous bodily functions. Zinc aspartate plays a crucial role in over 300 enzymatic processes, DNA and protein synthesis, cell growth, and wound healing. It also exhibits immunomodulatory, antioxidant, anti-inflammatory, and antimicrobial properties. Studies have explored its potential in stimulating immune responses, such as tetanus antibody formation and T lymphocyte activation, particularly in zinc-deficient individuals like chronic hemodialysis patients. Additionally, it has been investigated for its therapeutic potential in conditions like obesity, inflammatory bowel disease, osteoporosis, and rheumatoid arthritis.

Brand names
ZINKOTASE
Other names
zinc L-aspartateL-Aspartic Acid Zinc SaltBis(aspartato)zincZink DL-aspartatZink DL-hydrogenasparaginatUnizinkZincasZinkaspartZinkotase
02

Targets

IFNL3 (Interferon lambda 3)

Beyond the preview

Go deeper on zinc aspartate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on zinc aspartate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call